S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
BAC   32.70 (-0.27%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
BAC   32.70 (-0.27%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
BAC   32.70 (-0.27%)
DIS   147.15 (-1.06%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
PRI   130.20 (+1.24%)
BAC   32.70 (-0.27%)
DIS   147.15 (-1.06%)
Log in

Sartorius Stock Price, Forecast & Analysis (ETR:SRT)

€163.00
+2.00 (+1.24 %)
(As of 11/14/2019 04:00 PM ET)
Today's Range
€160.50
Now: €163.00
€163.00
50-Day Range
€144.50
MA: €154.63
€165.00
52-Week Range
€90.40
Now: €163.00
€179.00
Volume339 shs
Average VolumeN/A
Market Capitalization$5.58 billion
P/E Ratio64.97
Dividend Yield0.39%
BetaN/A
Sartorius Aktiengesellschaft supplies pharmaceutical and laboratory equipment worldwide. It operates in two divisions, Bioprocess Solutions, and Lab Products & Services. The company offers products for suspension cell analysis and live-cell analysis inside incubator for oncology, immuno-oncology, antibody discovery, neuroscience, and stem cell research; cell culture media, including antibody and recombinant protein, viral vaccines, and regenerative medicine media, as well as general media and downstream buffers; and multi-parallel, single-use, benchtop, stainless steel, microbial, and cell culture bioreactors, as well as cell culture expansion systems and software applications for bioreactors. Read More…

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone49 551 308 0

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.77 billion
Cash Flow€1.23 per share
Book Value€12.10 per share

Profitability

Miscellaneous

Employees8,125
Market Cap$5.58 billion
Next Earnings DateN/A
OptionableOptionable

Receive SRT News and Ratings via Email

Sign-up to receive the latest news and ratings for SRT and its competitors with MarketBeat's FREE daily newsletter.


Sartorius (ETR:SRT) Frequently Asked Questions

What is Sartorius' stock symbol?

Sartorius trades on the ETR under the ticker symbol "SRT."

Has Sartorius been receiving favorable news coverage?

News coverage about SRT stock has trended somewhat negative recently, InfoTrie reports. The research firm identifies negative and positive press coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Sartorius earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View News Stories for Sartorius.

Who are some of Sartorius' key competitors?

What other stocks do shareholders of Sartorius own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sartorius investors own include Align Technology (ALGN), Natus Medical (BABY), Cerner (CERN), Concert Pharmaceuticals (CNCE), Cytokinetics (CYTK), Deciphera Pharmaceuticals (DCPH), Endologix (ELGX), Epizyme (EPZM), EXACT Sciences (EXAS) and Fate Therapeutics (FATE).

Who are Sartorius' key executives?

Sartorius' management team includes the folowing people:
  • Dr. Joachim Kreuzburg, Chairman of Exec. Board & CEO (Age 54)
  • Mr. Rainer Lehmann, CFO & Member of Exec. Board and Head of Fin., Information Technology & Bus. Process (Age 43)
  • Ms. Petra Kirchhoff, Head of Corp. Communications & Investor Relations and Member of Supervisory Board (Age 50)
  • Mr. Gerry Mackay, Head of Lab Products & Services Division & Member of Exec. Board (Age 56)
  • Dr. René Fáber, Head of Bioprocess Solutions Division & Member of Exec. Board (Age 43)

What is Sartorius' stock price today?

One share of SRT stock can currently be purchased for approximately €163.00.

How big of a company is Sartorius?

Sartorius has a market capitalization of $5.58 billion and generates $1.77 billion in revenue each year. Sartorius employs 8,125 workers across the globe.View Additional Information About Sartorius.

What is Sartorius' official website?

The official website for Sartorius is http://www.sartorius.com/.

How can I contact Sartorius?

The company can be reached via phone at 49 551 308 0.


MarketBeat Community Rating for Sartorius (ETR SRT)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  35 (Thanks for Voting!)
Underperform Votes:  52 (Thanks for Voting!)
Total Votes:  87
MarketBeat's community ratings are surveys of what our community members think about Sartorius and other stocks. Vote "Outperform" if you believe SRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: Most Active Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel